v3.26.1
Stock-based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following is a summary of the Company’s stock options activity (as adjusted for the Exchange Ratio established in the Reverse Recapitalization) during the six months ended June 30, 2026):

Number of
Options		Weighted
average
exercise price
(USD)		Weighted
average
remaining
contractual
term
(years)		Aggregate
intrinsic
value
(USD)
Balance as of December 31, 202549,486,556$1.19 6.65$290,074 
Granted— — 
Exercised2,065,4340.67 
Expired and forfeited454,6191.44 
Balance as of June 30, 202646,966,503$1.21 7.01$511,916 
Exercisable as of June 30, 202632,745,059$0.72 7.18$373,068 
Unvested as of June 30, 202614,221,444$2.35 5.29$138,848 
Schedule of Nonvested Restricted Stock Units Activity
The following is a summary of the Company’s RSU activity during the six months ended June 30, 2026:
Number of RSU'sWeighted Average Grant
Date Fair Value (USD)
Balance as of December 31, 2025—$— 
Granted3,017,276 14.28 
Expired and forfeited6,97612.52 
Balance as of June 30, 20263,010,300$14.29 
Vested as of June 30, 202655,896$16.93 
Unvested as of June 30, 20262,954,404$14.24 
Schedule of Stock-based Compensation Expense
The following table summarizes the stock-based compensation expense related to stock options and RSUs classified in the consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2026 and 2025:
Three months ended
June 30,		Six months ended
June 30,
2026202520262025
Cost of revenue
$5 $8 $42 $17 
Research and development
2,544 677 3,588 1,320 
General and administrative
2,088 145 2,394 285 
Sales and marketing
41 18 62 36 
Total stock-based compensation expense
$4,678 $848 $6,086 $1,658